VJHemOnc is committed to improving our service to you

ASH 2019 | Update on the CLL treatment landscape

VJHemOnc is committed to improving our service to you

Lydia Scarfò

Lydia Scarfò, MD, Vita-Salute San Raffaele University, Milan, Italy, explains how the chronic lymphocytic leukemia (CLL) treatment landscape has evolved in recent years, including the occurrence of resistance to novel targeted therapies. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter